{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:51:50Z","timestamp":1794293510664,"version":"4.9.0"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Cytokines influence cell-fate decisions of na\u00efve lymphocytes and determine outcome of immune responses by transducing signals that regulate the initiation, intensity and duration of immune responses. However, aberrant regulation of physiological levels of cytokines contribute to the development of autoimmune and other inflammatory diseases. The Interleukin 6 (IL-6)\/IL-12 superfamily of cytokines have a profound influence on all aspects of host immunity and our focus in this review is on the signaling pathways that mediate their functions, with emphasis on how this enigmatic family of cytokines promote or suppress inflammation depending on the physiological context. We also describe regulatory lymphocyte populations that suppress neuroinflammatory diseases by producing cytokines, such as IL-27 (i27-Breg) or IL-35 (i35-Breg and iT\n                    <jats:sub>R<\/jats:sub>\n                    35). We conclude with emerging immunotherapies like STAT-specific Nanobodies, Exosomes and Breg therapy that ameliorate CNS autoimmune diseases in preclinical studies.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1514080","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T01:50:38Z","timestamp":1741225838000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["IL-6\/IL-12 superfamily of cytokines and regulatory lymphocytes play critical roles in the etiology and suppression of CNS autoimmune diseases"],"prefix":"10.3389","volume":"16","author":[{"given":"Manoj Kumar","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samara P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Egwuagu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120211","article-title":"Insights into cytokine-receptor interactions from cytokine engineering","volume":"33","author":"Spangler","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/(ISSN)1521-4141","article-title":"Historical insights into cytokines","author":"Dinarello","year":"2007","journal-title":"Eur J Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5332.1630","article-title":"STATs and gene regulation","volume":"277","author":"Darnell","year":"1997","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1101\/gad.14.14.1693","article-title":"Lineage commitment in the immune system: the T helper lymphocyte grows up","volume":"14","author":"Glimcher","year":"2000","journal-title":"Genes Dev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-078154","article-title":"CD4 T cells: fates, functions, and faults","volume":"112","author":"Zhu","year":"2008","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109548118","article-title":"IL-27-producing B-1a cells suppress neuroinflammation and CNS autoimmune diseases","volume":"118","author":"Choi","year":"2021","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B9","doi-asserted-by":"publisher","first-page":"166607","DOI":"10.1016\/j.jmb.2020.07.019","article-title":"Interleukin 35 regulatory B cells","volume":"433","author":"Choi","year":"2021","journal-title":"J Mol Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301132","article-title":"SOCS3 deletion in T-lymphocytes suppresses development of chronic ocular inflammation via up-regulation of CTLA-4 and expansion of regulatory T cells","volume":"191","author":"Yu","year":"2013","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-7688","article-title":"Suppressor of cytokine signaling-1 (SOCS1) inhibits lymphocyte recruitment into the retina and protects SOCS1 transgenic rats and mice from ocular inflammation","volume":"52","author":"Yu","year":"2011","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0338","article-title":"Interleukin 6: from bench to bedside","volume":"2","author":"Nishimoto","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.1083901","article-title":"Hexameric structure and assembly of the interleukin-6\/IL-6 alpha-receptor\/gp130 complex","volume":"300","author":"Boulanger","year":"2003","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0066-7","article-title":"Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer","volume":"18","author":"Jones","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.33.20138","article-title":"Influence of interleukin-6 (IL-6) dimerization on formation of the high affinity hexameric IL-6.receptor complex","volume":"271","author":"Ward","year":"1996","journal-title":"J Biol Chem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2015.07.001","article-title":"The soluble interleukin-6 receptor and related proteins","volume":"29","author":"Rose-John","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830230226","article-title":"The soluble interleukin-6 receptor is generated by shedding","volume":"23","author":"Mullberg","year":"1993","journal-title":"Eur J Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2015.07.011","article-title":"Family reunion\"\u2013A structured view on the composition of the receptor complexes of interleukin-6-type and interleukin-12-type cytokines","volume":"26","author":"Rose-John","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s000180050396","article-title":"Negative regulators of cytokine signal transduction","volume":"55","author":"Hilton","year":"1999","journal-title":"Cell Mol Life Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.1.114","article-title":"Twenty proteins containing a C-terminal SOCS box form five structural classes","volume":"95","author":"Hilton","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028415","article-title":"Interleukin-6 family cytokines","volume":"10","author":"Rose-John","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/368339a0","article-title":"Impaired immune and acute-phase responses in interleukin-6-deficient mice","volume":"368","author":"Kopf","year":"1994","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.14.8222","article-title":"Interleukin 6 plays a key role in the development of antigen-induced arthritis","volume":"95","author":"Ohshima","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.4.461","article-title":"Interleukin 6 is required for the development of collagen-induced arthritis","volume":"187","author":"Alonzi","year":"1998","journal-title":"J Exp Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/75068","article-title":"Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo","volume":"6","author":"Atreya","year":"2000","journal-title":"Nat Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/10.5.703","article-title":"IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein","volume":"10","author":"Okuda","year":"1998","journal-title":"Int Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/DDDT.S150580","article-title":"Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection","volume":"13","author":"Biggioggero","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3691","article-title":"Mechanisms and consequences of Jak-STAT signaling in the immune system","volume":"18","author":"Villarino","year":"2017","journal-title":"Nat Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00726-8","article-title":"Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach","volume":"18","author":"Tanaka","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.201","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"16","author":"Schwartz","year":"2017","journal-title":"Nat Rev Drug Discovery"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.9.6070","article-title":"Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases","volume":"180","author":"Liu","year":"2008","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.7.4313","article-title":"Cutting edge: An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity","volume":"179","author":"Harris","year":"2007","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"key":"B34","article-title":"Interleukin 27 containing exosomes (i27-exosomes) secreted by Retinal Microglia Suppress Uveitis","volume":"65","author":"Yadav","year":"2024","journal-title":"Invest Ophthalmol Visual Science"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.724609","article-title":"STAT3-specific single domain nanobody inhibits expansion of pathogenic th17 responses and suppresses uveitis in mice","volume":"12","author":"Mbanefo","year":"2021","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00856-y","article-title":"Targeting IL-6 trans-signalling: past, present and future prospects","volume":"23","author":"Rose-John","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1053\/j.gastro.2021.02.062","article-title":"Therapeutic interleukin-6 trans-signaling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease","volume":"160","author":"Schreiber","year":"2021","journal-title":"Gastroenterology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.1084","article-title":"Effect of induction therapy with olamkicept vs placebo on clinical response in patients with active ulcerative colitis: A randomized clinical trial","volume":"329","author":"Zhang","year":"2023","journal-title":"JAMA"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318211ff56","article-title":"Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model","volume":"39","author":"Barkhausen","year":"2011","journal-title":"Crit Care Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(03)00296-6","article-title":"The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses","volume":"19","author":"Trinchieri","year":"2003","journal-title":"Immunity"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00479","article-title":"Expanding diversity in molecular structures and functions of the IL-6\/IL-12 heterodimeric cytokine family","volume":"7","author":"Hasegawa","year":"2016","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2015.01.030","article-title":"Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease","volume":"75","author":"Sun","year":"2015","journal-title":"Cytokine"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/nri2225","article-title":"How microorganisms tip the balance between interleukin-12 family members","volume":"8","author":"Goriely","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41467-017-00838-4","article-title":"IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease","volume":"8","author":"Dambuza","year":"2017","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01258","article-title":"IL-12p35 inhibits neuroinflammation and ameliorates autoimmune encephalomyelitis","volume":"8","author":"Choi","year":"2017","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3554","article-title":"Interleukin-35 induces regulatory B cells that suppress autoimmune disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"B50","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/08830180212063","article-title":"Th1 and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis","volume":"21","author":"Caspi","year":"2002","journal-title":"Int Rev Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/nm1585","article-title":"T(H)17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","author":"Amadi-Obi","year":"2007","journal-title":"Nat Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.2.1143-1153.1996","article-title":"A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes","volume":"70","author":"Devergne","year":"1996","journal-title":"J virology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.22.12041","article-title":"Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin","volume":"94","author":"Devergne","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(02)00324-2","article-title":"IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells","volume":"16","author":"Pflanz","year":"2002","journal-title":"Immunity"},{"key":"B56","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev.cb.10.110194.000511","article-title":"Signal sequence recognition and protein targeting to the endoplasmic reticulum membrane","volume":"10","author":"Walter","year":"1994","journal-title":"Annu Rev Cell Biol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-4666(03)00016-4","article-title":"Intracellular localization of the p35 subunit of murine IL-12","volume":"21","author":"Vaidyanathan","year":"2003","journal-title":"Cytokine"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.623725","article-title":"Uveitis: molecular pathogenesis and emerging therapies","volume":"12","author":"Egwuagu","year":"2021","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/nri2548","article-title":"A molecular trio in relapse and remission in multiple sclerosis","volume":"9","author":"Steinman","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/BF00163549","article-title":"The natural history of uveitis","volume":"14","author":"Nussenblatt","year":"1990","journal-title":"Int Ophthalmol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/nature12979","article-title":"IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases","volume":"507","author":"Shen","year":"2014","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1952","article-title":"IL-35-mediated induction of a potent regulatory T cell population","volume":"11","author":"Collison","year":"2010","journal-title":"Nat Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.10.090","article-title":"Reciprocal expression of IL-35 and IL-10 defines two distinct effector treg subsets that are required for maintenance of immune tolerance","volume":"21","author":"Wei","year":"2017","journal-title":"Cell Rep"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0346-9","article-title":"Adaptive plasticity of IL-10(+) and IL-35(+) Treg cells cooperatively promotes tumor T cell exhaustion","volume":"20","author":"Sawant","year":"2019","journal-title":"Nat Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg6874","article-title":"Human interleukin-12alpha and EBI3 are cytokines with anti-inflammatory functions","volume":"9","author":"Hildenbrand","year":"2023","journal-title":"Sci Adv"},{"key":"B66","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri3470","article-title":"Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks","volume":"13","author":"Murphy","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3287","article-title":"Regulation of bifurcating B cell trajectories by mutual antagonism between transcription factors IRF4 and IRF8","volume":"16","author":"Xu","year":"2015","journal-title":"Nat Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1101\/sqb.2013.78.020305","article-title":"The molecular choreography of IRF4 and IRF8 with immune system partners","volume":"78","author":"Singh","year":"2013","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.3A0218-071RRR","article-title":"Production of IL-35 by Bregs is mediated through binding of BATF-IRF-4-IRF-8 complex to il12a and ebi3 promoter elements","volume":"104","author":"Yu","year":"2018","journal-title":"J Leukoc Biol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01051","article-title":"Interleukin 35-producing exosomes suppress neuroinflammation and autoimmune uveitis","volume":"11","author":"Kang","year":"2020","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700943","article-title":"A hard(y) look at B-1 cell development and function","volume":"199","author":"Baumgarth","year":"2017","journal-title":"J Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1071162","article-title":"IL-27-containing exosomes secreted by innate B-1a cells suppress and ameliorate uveitis","volume":"14","author":"Kang","year":"2023","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.celrep.2019.12.081","article-title":"Treg-cell-derived IL-35-coated extracellular vesicles promote infectious tolerance","volume":"30","author":"Sullivan","year":"2020","journal-title":"Cell Rep"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20080155","article-title":"Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis","volume":"205","author":"Lees","year":"2008","journal-title":"J Exp Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12974-018-1237-y","article-title":"An IFNgamma\/CXCL2 regulatory pathway determines lesion localization during EAE","volume":"15","author":"Stoolman","year":"2018","journal-title":"J Neuroinflammation"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400825","article-title":"Site-specific chemokine expression regulates central nervous system inflammation and determines clinical phenotype in autoimmune encephalomyelitis","volume":"193","author":"Stoolman","year":"2014","journal-title":"J Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-063011-092449","article-title":"Nanobodies: natural single-domain antibodies","volume":"82","author":"Muyldermans","year":"2013","journal-title":"Annu Rev Biochem"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/cells13121042","article-title":"A camelid-derived STAT-specific nanobody inhibits neuroinflammation and ameliorates experimental autoimmune encephalomyelitis (EAE)","volume":"13","author":"Mbanefo","year":"2024","journal-title":"Cells"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1514080\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T01:50:42Z","timestamp":1741225842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1514080\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":78,"alternative-id":["10.3389\/fimmu.2025.1514080"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1514080","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]},"article-number":"1514080"}}